Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Kimball-Inspired Metadata Management: A Lecture by Ross Leishman of DWS Ltd | Steve Hocking, Group CEO of DWS Ltd
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Steve Hocking is the Group CEO of DWS Ltd
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Alberta Firm ClearFlow Develops Portable Solution for Cleaning Oil Industry Wastewater
00:10:00
invest in companies where AI is a core component|Fang Yuan,General Partner,AIX Ventures
00:10:00
Barnes Group: Crafting Connecticut's Success | Thomas J. Hook - President & Chief Executive Officer of Barnes
00:10:00
Beyond the Horizon: Strategies for the Next Generation of Companies|Andrew Schoen,Partner,New Enterprise Associates (NEA)
00:10:00
CMC Metals Ltd. CEO Kevin Brewer Showcases Excellence at Metals Investor Forum 2023 in Toronto | Kevin Brewer, President, CEO and Director of CMC Metals Ltd.
00:10:00
Relief Therapeutics is a Swiss commercial stage biopharmaceutical company,Raghuram,Chairman,Relief Therapeutics
00:10:00
Francis Wedin Highlights Vulcan's Sustainable Lithium Brine Project | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:00:00
Frédéric Cren Chief Executive Officer, Inventiva
00:10:00
Understanding Retirement and Pensions in the UK: Explained by BlackRock | Rachel Lord, CEO, BlackRock UK
00:00:00
Jesse D. Bracamonte, D.O.
00:10:00
solve problems and multiply the benefits of capitalism for everyone while reducing its cost|Dr. Kiersten Stead,Managing Partner, DCVC Bio,DCVC
00:10:00
Archer Exploration: Advancing Nickel Sulfide Projects in Ontario and Quebec